Anavex Life Sciences News

Anavex Life Sciences | 10-Q: Quarterly report

Futu News04:39 · Announcements

Buy Rating on Anavex Life Sciences Amid Promising Alzheimer's Drug Prospects

TipRanks01:45

Anavex Life Sciences Corp. (AVXL) Q2 2024 Earnings Call Transcript

Anavex Life Sciences Corp. (AVXL) Q2 2024 Earnings Call Transcript

Earnings Call TranscriptsMay 9 22:10

Anavex Life Sciences Q2 2024 GAAP EPS $(0.13) Misses $(0.11) Estimate, Cash and Equivalents of $139.4M

Anavex Life Sciences (NASDAQ:AVXL) reported quarterly losses of $(0.13) per share which missed the analyst consensus estimate of $(0.11) by 18.18 percent. This is a 176.47 percent decrease over earnin

BenzingaMay 9 19:34

Press Release: Anavex Life Sciences Reports Fiscal 2024 Second Quarter Financial Results and Provides Business Update

Anavex Life Sciences Reports Fiscal 2024 Second Quarter Financial Results and Provides Business Update Company to host a webcast today at 8:30 a.m. Eastern Time NEW YORK, May 09, 2024 (GLOBE NEWSWIR

Dow JonesMay 9 19:30

Anavex Life Sciences 2Q Loss/Shr 13c >AVXL

Anavex Life Sciences 2Q Loss/Shr 13c >AVXL

Dow JonesMay 9 19:30

Anavex Life Sciences to Announce Fiscal 2024 Second Quarter Financial Results on Thursday, May 9th, 2024

NEW YORK, May 02, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ:AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of

GlobeNewswireMay 2 19:30

Anavex Life Sciences to Present at the Noble Capital Markets Virtual Healthcare Equity Conference

NEW YORK, April 11, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ:AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of

GlobeNewswireApr 11 19:30

Companies Like Anavex Life Sciences (NASDAQ:AVXL) Are In A Position To Invest In Growth

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the right price. For example, biotech and mining exploration companies often lose mo

Simply Wall StApr 5 20:00

Anavex Life Sciences(AVXL.US) Officer Sells US$374.97K in Common Stock

$Anavex Life Sciences(AVXL.US)$ Officer MISSLING CHRISTOPHER U sold 73,380 shares of Common Stock on Mar 28, 2024 at an average price of $5.11 for a total value of $374.97K.Source: Announcement What i

Futu NewsApr 2 06:41

Form 144 | Anavex Life Sciences(AVXL.US) Officer Proposes to Sell 371.3K in Common Stocks

SEC FILLINGS DISCLOSED/ Mar 28, $Anavex Life Sciences(AVXL.US)$ Officer MISSLING CHRISTOPHER U intends to sell 73,380 shares of its common stock on Mar 28, with a total market value of approximately $

Futu NewsMar 28 20:39

Anavex Life Sciences to Present at the 23rd Annual Needham Virtual Healthcare Conference

NEW YORK, March 25, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ:AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of

GlobeNewswireMar 25 19:30

Anavex Life Sciences Announced That The First Patient In Its Phase 2 Study Of ANAVEX3-71 For Schizophrenia Has Been Screened Ahead Of Schedule

Anavex Life Sciences Announced That The First Patient In Its Phase 2 Study Of ANAVEX3-71 For Schizophrenia Has Been Screened Ahead Of Schedule

BenzingaMar 18 19:35

AVLX, SGH and ETNB Are Among Pre Market Losers

Seeking AlphaMar 16 04:48

12 $10 Stocks That Will Triple

Yahoo FinanceFeb 27 02:14

Anavex Life Sciences to Present at the 44th Annual TD Cowen Health Care Conference

NEW YORK, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ:AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of

GlobeNewswireFeb 26 20:30

Analysts Offer Insights on Healthcare Companies: Anavex Life Sciences (AVXL), PolyPid (PYPD) and Nyxoah (NYXH)

TipRanksFeb 15 19:30

Anavex Life Sciences Corp. (NASDAQ:AVXL) Q1 2024 Earnings Call Transcript

Yahoo FinanceFeb 8 22:39

Earnings Call Summary | Anavex Life Sciences(AVXL.US) Q1 2024 Earnings Conference

The following is a summary of the Anavex Life Sciences Corp. (AVXL) Q1 2024 Earnings Call Transcript:Financial Performance:Anavex Life Sciences reported a cash position of $143.8 million for Q1 2024,

Futu NewsFeb 8 02:52 · Conference Call

Buy Rating Affirmed for Anavex Life Sciences Amid Positive Alzheimer's Program Outlook and Financial Stability

TipRanksFeb 8 00:55